Overview

Prospective Study of Stereotactic Radiology Using Diffusion-Weighted Abnormality Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy

Status:
Completed

Trial end date:
2016-12-01

Target enrollment:

Participant gender:

Summary

This clinical trial is a prospective study of radiosurgery treatment for progressive GBM to test 1)the efficacy of radiosurgery for recurrent/progressive GBM compared to chemotherapy , and 2) the role of diffusion-weighted image (DWI) to predict the early tumor progression and treatment response.

Phase:

Phase 3

Details

Lead Sponsor:

Henry Ford Health System

Treatments:

Bevacizumab
Carboplatin
Etoposide
Irinotecan
Temozolomide